Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium (Q35600437)

9 August 2017

1 reference

title

Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium (English)

1 reference

9 August 2017

0 references

1 reference

2

Martin Weger

1 reference

9 August 2017

Olaf Stanger

1

1 reference

PubMed ID

14656024

9 August 2017

language of work or name

1 reference

1 November 2003

1 reference

Clinical Chemistry and Laboratory Medicine

9 August 2017

1 reference

9 August 2017

41

1 reference

9 August 2017

1444-1454

1 reference

9 August 2017

11

1 reference

Homocysteine and cardiovascular disease

9 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Dietary folate and the risk of nonfatal myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Serum folate levels and subsequent adverse cerebrovascular outcomes in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Physiology of folic acid in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

The pathogenesis of atherosclerosis: a perspective for the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Endothelial dysfunction: a marker of atherosclerotic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

The oxidant stress of hyperhomocyst(e)inemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Impaired nitric oxide-mediated flow-induced coronary dilation in hyperhomocysteinemia: morphological and functional evidence for increased peroxynitrite formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Effects of folate treatment and homocysteine lowering on resistance vessel reactivity in atherosclerotic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Folic acid improves arterial endothelial function in adults with hyperhomocystinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Oral folate enhances endothelial function in hyperhomocysteinaemic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Methionine metabolism in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Enzymatic function of nitric oxide synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Structure-function aspects in the nitric oxide synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Tetrahydrobiopterin binding to macrophage inducible nitric oxide synthase: heme spin shift and dimer stabilization by the potent pterin antagonist 4-amino-tetrahydrobiopterin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

In search of a function for tetrahydrobiopterin in the biosynthesis of nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Nitric oxide as a challenge for the clinical chemistry laboratory

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Plasma nitrosothiols contribute to the systemic vasodilator effects of intravenously applied NO: experimental and clinical Study on the fate of NO in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

An L-arginine/nitric oxide pathway present in human platelets regulates aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Regulation of basal myocardial function by NO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Nitric oxide and thiol groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Xanthine oxidase-derived reactive oxygen species convert flow-induced arteriolar dilation to constriction in hyperhomocysteinemia: possible role of peroxynitrite

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Presence of excess tetrahydrobiopterin during nitric oxide production from inducible nitric oxide synthase in LPS-treated rat aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Reactive oxygen species as mediators of signal transduction in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

New insights into mechanisms underlying nitrate tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

The cardiovascular effects and implications of peroxynitrite

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

HMG-CoA reductase inhibitor increases GTP cyclohydrolase I mRNA and tetrahydrobiopterin in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Tetrahydrobiopterin attenuates homocysteine induced endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Lipid peroxidation induced in vivo by hyperhomocysteinaemia in pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Taurine prevents the decrease in expression and secretion of extracellular superoxide dismutase induced by homocysteine: amelioration of homocysteine-induced endoplasmic reticulum stress by taurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Inducible nitric oxide synthase: identification of amino acid residues essential for dimerization and binding of tetrahydrobiopterin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Altered tetrahydrobiopterin metabolism in atherosclerosis: implications for use of oxidized tetrahydrobiopterin analogues and thiol antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

A synthetic peptide corresponding to the putative dihydrofolate reductase domain of nitric oxide synthase inhibits uncoupled NADPH oxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Folate protects against oxidative modification of human LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Vitamins C, E and A and heme oxygenase in rats fed methyl/folate-deficient diets

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Smooth muscle cell expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Dietary supplement with vitamin C prevents nitrate tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

NO-dependent vasorelaxation is impaired after gene transfer of inducible NO-synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Effects of infusion of L-arginine into the left anterior descending coronary artery on acetylcholine-induced vasoconstriction of human atheromatous coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

Lowering plasma homocysteine with folic acid in cardiovascular disease: what will the trials tell us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

The nature of endothelium-derived vascular relaxant factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.222

21 January 2018

Identifiers

DOI

10.1515/CCLM.2003.222

1 reference

9 August 2017

1 reference

PubMed ID

14656024